Literature DB >> 26201767

The BAFFling problem of B cell-activating factor in nonalcoholic fatty liver disease.

Puneet Puri1, Arun J Sanyal2.   

Abstract

Entities:  

Year:  2013        PMID： 26201767      PMCID： PMC4871813          DOI： 10.1007/s12072-012-9418-8

Source DB:  PubMed          Journal:  Hepatol Int        ISSN： 1936-0533            Impact factor:   6.047


× No keyword cloud information.
  24 in total

Review 1.  Mallory bodies revisited.

Authors:  H Denk; C Stumptner; K Zatloukal
Journal:  J Hepatol       Date:  2000-04       Impact factor: 25.083

Review 2.  BAFF AND APRIL: a tutorial on B cell survival.

Authors:  Fabienne Mackay; Pascal Schneider; Paul Rennert; Jeffrey Browning
Journal:  Annu Rev Immunol       Date:  2001-12-19       Impact factor: 28.527

Review 3.  Intermediate filament proteins of the liver: emerging disease association and functions.

Authors:  M B Omary; N O Ku
Journal:  Hepatology       Date:  1997-05       Impact factor: 17.425

4.  Elevated serum B-Lymphocyte activating factor (BAFF) in chronic hepatitis C virus infection: association with autoimmunity.

Authors:  E Toubi; S Gordon; A Kessel; I Rosner; M Rozenbaum; Y Shoenfeld; E Zuckerman
Journal:  J Autoimmun       Date:  2006-10-06       Impact factor: 7.094

5.  Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial.

Authors:  Sandra V Navarra; Renato M Guzmán; Alberto E Gallacher; Stephen Hall; Roger A Levy; Renato E Jimenez; Edmund K-M Li; Mathew Thomas; Ho-Youn Kim; Manuel G León; Coman Tanasescu; Eugeny Nasonov; Joung-Liang Lan; Lilia Pineda; Z John Zhong; William Freimuth; Michelle A Petri
Journal:  Lancet       Date:  2011-02-04       Impact factor: 79.321

Review 6.  BAFF and innate immunity: new therapeutic targets for systemic lupus erythematosus.

Authors:  Fabien B Vincent; Eric F Morand; Fabienne Mackay
Journal:  Immunol Cell Biol       Date:  2012-01-10       Impact factor: 5.126

7.  Adipocytes as immune cells: differential expression of TWEAK, BAFF, and APRIL and their receptors (Fn14, BAFF-R, TACI, and BCMA) at different stages of normal and pathological adipose tissue development.

Authors:  Vassilia-Ismini Alexaki; George Notas; Vassiliki Pelekanou; Marilena Kampa; Maria Valkanou; Panayiotis Theodoropoulos; Efstathios N Stathopoulos; Andreas Tsapis; Elias Castanas
Journal:  J Immunol       Date:  2009-10-14       Impact factor: 5.422

8.  Expression of B-cell activating factor of the tumour necrosis factor family (BAFF) in T cells in active systemic lupus erythematosus: the role of BAFF in T cell-dependent B cell pathogenic autoantibody production.

Authors:  S Morimoto; S Nakano; T Watanabe; Y Tamayama; A Mitsuo; Y Nakiri; J Suzuki; K Nozawa; H Amano; Y Tokano; T Kobata; Y Takasaki
Journal:  Rheumatology (Oxford)       Date:  2007-05-11       Impact factor: 7.580

9.  BAFF, a novel ligand of the tumor necrosis factor family, stimulates B cell growth.

Authors:  P Schneider; F MacKay; V Steiner; K Hofmann; J L Bodmer; N Holler; C Ambrose; P Lawton; S Bixler; H Acha-Orbea; D Valmori; P Romero; C Werner-Favre; R H Zubler; J L Browning; J Tschopp
Journal:  J Exp Med       Date:  1999-06-07       Impact factor: 14.307

10.  Expression of TNF-superfamily members BAFF and APRIL in breast cancer: immunohistochemical study in 52 invasive ductal breast carcinomas.

Authors:  Vassiliki Pelekanou; Marilena Kampa; Maria Kafousi; Katerina Darivianaki; Elias Sanidas; Dimitrios D Tsiftsis; Efstathios N Stathopoulos; Andreas Tsapis; Elias Castanas
Journal:  BMC Cancer       Date:  2008-03-20       Impact factor: 4.430
View more
  2 in total

Review 1.  Noncanonical NF-κB Signaling Pathway in Liver Diseases.

Authors:  Qianhui Chen; Xinyu Lu; Xiaoyong Zhang
Journal:  J Clin Transl Hepatol       Date:  2020-12-21

2.  B-Cell Activating Factor Enhances Hepatocyte-Driven Angiogenesis via B-Cell CLL/Lymphoma 10/Nuclear Factor-KappaB Signaling during Liver Regeneration.

Authors:  Chia-Hung Chou; Cheng-Maw Ho; Shou-Lun Lai; Chiung-Nien Chen; Yao-Ming Wu; Chia-Tung Shun; Wen-Fen Wen; Hong-Shiee Lai
Journal:  Int J Mol Sci       Date:  2019-10-10       Impact factor: 5.923
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.